Progyny Inc (PGNY) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Progyny Inc   (NASDAQ: PGNY)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Progyny Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Progyny Inc's ROI in the second quarter of 2026?
Progyny Inc achieved a return on average invested assets (ROI) of 15.25 % in its second quarter of 2026, which is below Progyny Inc's average return on investment, which stands at 22.32%.

ROI has improved compared to 12.72% in the first quarter of 2026, due to net income growth.

Within the Healthcare sector 56 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 617 to 618.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 7.25 % 14.63 % 10.6 % -1.6 % -11.43 %
Y / Y Net Income Change TTM 48.02 % 28.95 % 56.31 % 110.24 % 222.26 %
Investment (TTM) in Millions 476 463 540 585 541
Return On Investment (TTM) 15.25 % 12.72 % 10.84 % 11 % 11.05 %
PGNY's Overall Ranking # 618 # 617 # 506 # 472 # 544
Seq. Investment Change TTM -3.04 % -1.42 % 4.94 % 6.93 % 3.62 %
Seq. Net Income Change TTM 16.16 % 15.67 % 3.45 % 6.48 % 1.19 %
Net Income (TTM) in Millions 79 68 59 57 53

PGNY Company Profile >> Back to PGNY Roi Comparisons >> See Annual PGNY Return On Investment



Return On Investment PGNY's Ranking
Within: No.
Industry # 3
Sector # 57
Overall # 618

Return On Investment Statistics
High Average Low
282.27 %
22.32 %
-219.12 %
(Dec 31 2019)   (Sep 30 2019)







Financial Statements
Progyny Inc's II. Quarter Investments $ 476 Millions PGNY's Balance sheet
Progyny Inc's II. Quarter Income $ 28 Millions Quarterly PGNY's Income Statement
PGNY's Income by Division See PGNY's Income by Division


PGNY Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 540 438 571 383 259
Y / Y Investment Growth 23.16 % -23.16 % 48.83 % 47.91 % 52.87 %
Net Income in Millions 59 54 62 30 66
Y / Y Net Income Growth 7.7 % -12.41 % 104.35 % -53.84 % 41.56 %
Annual Return On Investment 10.84 % 12.39 % 10.87 % 7.92 % 25.37 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 10.84 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PGNY's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PGNY's Competitors
Subscribers only: Roi for Progyny Inc's Suppliers
Subscribers only: Return On Investment for PGNY's Customers

Other Ratios
PGNY's Roa PGNY's Inventory Turnover Ratio PGNY's Growth Rates PGNY's Dividend Statistics
PGNY's Profitability Ratios PGNY's Asset Turnover Ratio PGNY's Dividend Growth
PGNY's Roe PGNY's Valuation Ratios PGNY's Financial Strength Ratios PGNY's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Tg Therapeutics Inc   39.26 %
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %

Date modified: 2026-08-14T20:54:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.